What are the major opportunities in the Proliferative Diabetic Retinopathy (PDR) market? What are the strategies for the Proliferative Diabetic Retinopathy (PDR) market?

For detailed insights on the major opportunities and strategies in the Proliferative Diabetic Retinopathy (PDR) market, Read More

How does the Proliferative Diabetic Retinopathy (PDR) market relate to the overall economy and other similar markets?

For detailed insights on Proliferative Diabetic Retinopathy (PDR)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Proliferative Diabetic Retinopathy (PDR) market growth? SWOT analysis of the Proliferative Diabetic Retinopathy (PDR) market.

For detailed insights on the key dynamics influencing the Proliferative Diabetic Retinopathy (PDR) market growth and SWOT analysis of the Proliferative Diabetic Retinopathy (PDR) industry, Read More

Proliferative Diabetic Retinopathy (PDR) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Proliferative Diabetic Retinopathy (PDR) Market Report 2026

Name: Proliferative Diabetic Retinopathy (PDR) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy), By Mode of Administration (Injectables, Intravitreal Administration Focus, Other Mode Of Administrations), By Application (Hospitals, Clinics, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Proliferative Diabetic Retinopathy (PDR) Market Overview

• Proliferative Diabetic Retinopathy (PDR) market size has reached to $2.69 billion in 2025

• Expected to grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 11%

• Growth Driver: Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopathy (PDR) Market

• Market Trend: Innovative Solutions For Early Detection And Improved Patient Outcomes

• North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Proliferative Diabetic Retinopathy (PDR) Market?

Proliferative diabetic retinopathy (PDR) refers to an advanced stage of diabetic eye disease characterized by the growth of abnormal blood vessels in the retina due to prolonged high blood sugar levels. These vessels can lead to retinal bleeding, scarring and vision impairment if left untreated, making regular eye examinations crucial for early detection and management.

The main treatment types of proliferative diabetic retinopathy are anti-VEGF (vascular endothelial growth factor) therapy, intraocular steroids, laser surgery and vitrectomy. Intraocular steroids are medications administered directly into the eye to manage inflammation and treat conditions like diabetic macular edema or uveitis, helping reduce swelling and improve visual outcomes. The various mode of administration includes injectables, oral and others that are used by various applications such as hospitals, clinics and others.

Proliferative Diabetic Retinopathy (PDR) Market Global Report 2026 Market Report bar graph

What Is The Proliferative Diabetic Retinopathy (PDR) Market Size and Share 2026?

The proliferative diabetic retinopathy (pdr) market size has grown rapidly in recent years. It will grow from $2.69 billion in 2025 to $2.96 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing prevalence of diabetes mellitus, wider use of retinal laser therapies, expansion of ophthalmology clinics, improved access to eye care services, growth in diabetic screening programs.

What Is The Proliferative Diabetic Retinopathy (PDR) Market Growth Forecast?

The proliferative diabetic retinopathy (pdr) market size is expected to see rapid growth in the next few years. It will grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing demand for long-acting injectable therapies, rising adoption of AI-based retinal diagnostics, expansion of outpatient ophthalmic procedures, growing focus on vision preservation strategies, increasing investment in diabetic eye disease management. Major trends in the forecast period include increasing adoption of anti-vegf therapies, rising use of advanced retinal imaging technologies, growing focus on early screening and diagnosis, expansion of minimally invasive surgical interventions, enhanced integration of multidisciplinary diabetes care.

Book your 30 minutes free consultation with our research experts

Global Proliferative Diabetic Retinopathy (PDR) Market Segmentation

1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy

2) By Mode of Administration: Injectables, Intravitreal Administration Focus, Other Mode Of Administrations

3) By Application: Hospitals, Clinics, Other Applications

Subsegments:

1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab

2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide

3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation

4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy

What Is The Driver Of The Proliferative Diabetic Retinopathy (PDR) Market?

The rising prevalence of diabetes is expected to propel the growth of the proliferative diabetic retinopathy (PDR) market going forward. Diabetes is a chronic medical condition characterized by elevated glucose (sugar) levels in the blood. Diabetes is the leading cause of proliferative diabetic retinopathy disease, which can be treated by various methods that prevent further damage to the retina and preserve vision. For instance, in June 2024, according to the National Health Service (NHS), UK-based government department, among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend in this age group. The data reflects a rapid escalation in diabetes prevalence among younger populations. Therefore, the rising prevalence of diabetes drives the proliferative diabetic retinopathy (PDR) industry.

Key Players In The Global Proliferative Diabetic Retinopathy (PDR) Market

Major companies operating in the proliferative diabetic retinopathy (pdr) market are Johnson And Johnson Limited, F Hoffmann La Roche Ltd, AbbVie Inc, Bayer AG, Novartis AG, Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation, Lumenis Ltd, Optos plc, Zeiss Meditec India Pvt Ltd, Alimera Sciences Inc

Global Proliferative Diabetic Retinopathy (PDR) Market Trends and Insights

Major companies operating in the proliferative diabetic retinopathy (PDR) market are focusing on developing innovative solutions such as AI-based autonomous retinal screening systems and handheld fundus cameras to enhance early detection and improve patient outcomes. AI-based autonomous screening systems are designed to analyze retinal images without human intervention, providing rapid and accurate identification of diabetic retinopathy, while handheld fundus cameras allow portable and accessible retinal imaging. For instance, in April 2024, Optomed Plc, a Finland-based medical technology company, received U.S. Food and Drug Administration (FDA) clearance for its Optomed Aurora with AEYE, a handheld AI fundus camera capable of autonomously detecting referable diabetic retinopathy, thereby expanding the accessibility and efficiency of PDR screening beyond traditional clinical settings.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Proliferative Diabetic Retinopathy (PDR) Market?

In July 2024, Merck and Co. Inc., a US-based healthcare company that develops and sells medicines, vaccines, and animal health products, acquired Eyebiotech Limited for a $3 billion amount. With this acquisition, Merck and Co., Inc. aims to enhance its ophthalmology pipeline by developing innovative therapies for sight-threatening retinal diseases and addressing significant unmet medical needs in this area. Eyebiotech Limited is a UK-based biotechnology company that focuses on developing therapies for proliferative diabetic retinopathy to combat abnormal retinal blood vessel growth.

Regional Outlook

North America was the largest region in the proliferative diabetic retinopathy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Proliferative Diabetic Retinopathy (PDR) Market?

The proliferative diabetic retinopathy (PDR) market consists of sales of laser therapy, systemic therapies and combination therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The proliferative diabetic retinopathy (PDR) market also includes sales of corticosteroids, ranibizumab, bevacizumab and fluocinolone acetonide drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Proliferative Diabetic Retinopathy (PDR) Market Report 2026?

The proliferative diabetic retinopathy (pdr) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the proliferative diabetic retinopathy (pdr) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Proliferative Diabetic Retinopathy (PDR) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.96 billion
Revenue Forecast In 2035	$4.49 billion
Growth Rate	CAGR of 10.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Mode of Administration, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Johnson And Johnson Limited, F Hoffmann La Roche Ltd, AbbVie Inc, Bayer AG, Novartis AG, Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation, Lumenis Ltd, Optos plc, Zeiss Meditec India Pvt Ltd, Alimera Sciences Inc
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Proliferative Diabetic Retinopathy (PDR) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Proliferative Diabetic Retinopathy (PDR) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Proliferative Diabetic Retinopathy (PDR) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Proliferative Diabetic Retinopathy (PDR) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Anti-Vegf Therapies

4.2.2 Rising Use Of Advanced Retinal Imaging Technologies

4.2.3 Growing Focus On Early Screening And Diagnosis

4.2.4 Expansion Of Minimally Invasive Surgical Interventions

4.2.5 Enhanced Integration Of Multidisciplinary Diabetes Care

5. Proliferative Diabetic Retinopathy (PDR) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmology Clinics

5.3 Specialty Eye Hospitals

5.4 Ambulatory Surgical Centers

5.5 Diagnostic Imaging Centers

6. Proliferative Diabetic Retinopathy (PDR) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Proliferative Diabetic Retinopathy (PDR) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Proliferative Diabetic Retinopathy (PDR) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Proliferative Diabetic Retinopathy (PDR) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Proliferative Diabetic Retinopathy (PDR) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Proliferative Diabetic Retinopathy (PDR) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Proliferative Diabetic Retinopathy (PDR) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Proliferative Diabetic Retinopathy (PDR) Market Segmentation

9.1. Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy

9.2. Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectables, Intravitreal Administration Focus, Other Mode Of Administrations

9.3. Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Other Applications

9.4. Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Aflibercept, Ranibizumab, Bevacizumab

9.5. Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Intraocular Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide

9.6. Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Laser Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Focal Laser Photocoagulation, Panretinal Laser Photocoagulation

9.7. Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Vitrectomy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pars Plana Vitrectomy, Anterior Vitrectomy

10. Proliferative Diabetic Retinopathy (PDR) Market Regional And Country Analysis

10.1. Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market

11.1. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Proliferative Diabetic Retinopathy (PDR) Market

12.1. China Proliferative Diabetic Retinopathy (PDR) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Proliferative Diabetic Retinopathy (PDR) Market

13.1. India Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Proliferative Diabetic Retinopathy (PDR) Market

14.1. Japan Proliferative Diabetic Retinopathy (PDR) Market Overview

14.2. Japan Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Proliferative Diabetic Retinopathy (PDR) Market

15.1. Australia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Proliferative Diabetic Retinopathy (PDR) Market

16.1. Indonesia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Proliferative Diabetic Retinopathy (PDR) Market

17.1. South Korea Proliferative Diabetic Retinopathy (PDR) Market Overview

17.2. South Korea Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Proliferative Diabetic Retinopathy (PDR) Market

18.1. Taiwan Proliferative Diabetic Retinopathy (PDR) Market Overview

18.2. Taiwan Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Proliferative Diabetic Retinopathy (PDR) Market

19.1. South East Asia Proliferative Diabetic Retinopathy (PDR) Market Overview

19.2. South East Asia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Proliferative Diabetic Retinopathy (PDR) Market

20.1. Western Europe Proliferative Diabetic Retinopathy (PDR) Market Overview

20.2. Western Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Proliferative Diabetic Retinopathy (PDR) Market

21.1. UK Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Proliferative Diabetic Retinopathy (PDR) Market

22.1. Germany Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Proliferative Diabetic Retinopathy (PDR) Market

23.1. France Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Proliferative Diabetic Retinopathy (PDR) Market

24.1. Italy Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Proliferative Diabetic Retinopathy (PDR) Market

25.1. Spain Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market

26.1. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market Overview

26.2. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Proliferative Diabetic Retinopathy (PDR) Market

27.1. Russia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Proliferative Diabetic Retinopathy (PDR) Market

28.1. North America Proliferative Diabetic Retinopathy (PDR) Market Overview

28.2. North America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Proliferative Diabetic Retinopathy (PDR) Market

29.1. USA Proliferative Diabetic Retinopathy (PDR) Market Overview

29.2. USA Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Proliferative Diabetic Retinopathy (PDR) Market

30.1. Canada Proliferative Diabetic Retinopathy (PDR) Market Overview

30.2. Canada Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Proliferative Diabetic Retinopathy (PDR) Market

31.1. South America Proliferative Diabetic Retinopathy (PDR) Market Overview

31.2. South America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Proliferative Diabetic Retinopathy (PDR) Market

32.1. Brazil Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Proliferative Diabetic Retinopathy (PDR) Market

33.1. Middle East Proliferative Diabetic Retinopathy (PDR) Market Overview

33.2. Middle East Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Proliferative Diabetic Retinopathy (PDR) Market

34.1. Africa Proliferative Diabetic Retinopathy (PDR) Market Overview

34.2. Africa Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Segmentation By Mode of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Proliferative Diabetic Retinopathy (PDR) Market Regulatory and Investment Landscape

36. Proliferative Diabetic Retinopathy (PDR) Market Competitive Landscape And Company Profiles

36.1. Proliferative Diabetic Retinopathy (PDR) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Proliferative Diabetic Retinopathy (PDR) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Proliferative Diabetic Retinopathy (PDR) Market Company Profiles

36.3.1. Johnson And Johnson Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Proliferative Diabetic Retinopathy (PDR) Market Other Major And Innovative Companies

Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation

38. Global Proliferative Diabetic Retinopathy (PDR) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Proliferative Diabetic Retinopathy (PDR) Market

40. Proliferative Diabetic Retinopathy (PDR) Market High Potential Countries, Segments and Strategies

40.1 Proliferative Diabetic Retinopathy (PDR) Market In 2030 - Countries Offering Most New Opportunities

40.2 Proliferative Diabetic Retinopathy (PDR) Market In 2030 - Segments Offering Most New Opportunities

40.3 Proliferative Diabetic Retinopathy (PDR) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Proliferative Diabetic Retinopathy (PDR) Market, Overview Of Key Products - Product Examples

Table 2: Global Proliferative Diabetic Retinopathy (PDR) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Proliferative Diabetic Retinopathy (PDR) Market, Supply Chain Analysis

Table 4: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Raw Material Providers

Table 5: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Resource Providers

Table 6: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Manufacturers (Suppliers)

Table 7: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Distributors And Channel Partners

Table 8: Global Proliferative Diabetic Retinopathy (PDR) Market, Key Technologies & Future Trends

Table 9: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Trends

Table 10: Global Proliferative Diabetic Retinopathy (PDR) Market, Major End Users

Table 11: Global Proliferative Diabetic Retinopathy (PDR) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Proliferative Diabetic Retinopathy (PDR) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Proliferative Diabetic Retinopathy (PDR) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Proliferative Diabetic Retinopathy (PDR) Market - TAM, US$ Billion, 2025

Table 15: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Intraocular Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Laser Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Vitrectomy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Proliferative Diabetic Retinopathy (PDR) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Proliferative Diabetic Retinopathy (PDR) Market - Company Scoring Matrix

Table 98: Johnson And Johnson Limited Financial Performance

Table 99: F Hoffmann La Roche Ltd Financial Performance

Table 100: AbbVie Inc Financial Performance

Table 101: Bayer AG Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Global Proliferative Diabetic Retinopathy (PDR) Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Proliferative Diabetic Retinopathy (PDR) Market, Competitive Dashboard

Table 105: Global Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 107: Global, Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), Segmentation By Mode of Administration, 2025 – 2030

Table 108: Global, Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Proliferative Diabetic Retinopathy (PDR) Market, Overview Of Key Products - Product Examples

Figure 2: Global Proliferative Diabetic Retinopathy (PDR) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Proliferative Diabetic Retinopathy (PDR) Market, Supply Chain Analysis

Figure 4: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Raw Material Providers

Figure 5: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Resource Providers

Figure 6: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Manufacturers (Suppliers)

Figure 7: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Distributors And Channel Partners

Figure 8: Global Proliferative Diabetic Retinopathy (PDR) Market, Key Technologies & Future Trends

Figure 9: Global Proliferative Diabetic Retinopathy (PDR) Market, Major Trends

Figure 10: Global Proliferative Diabetic Retinopathy (PDR) Market, Major End Users

Figure 11: Global Proliferative Diabetic Retinopathy (PDR) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Proliferative Diabetic Retinopathy (PDR) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Proliferative Diabetic Retinopathy (PDR) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Proliferative Diabetic Retinopathy (PDR) Market - TAM, US$ Billion, 2025

Figure 15: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Intraocular Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Laser Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Proliferative Diabetic Retinopathy (PDR) Market, Sub-Segmentation Of Vitrectomy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Proliferative Diabetic Retinopathy (PDR) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Proliferative Diabetic Retinopathy (PDR) Market - Company Scoring Matrix

Figure 98: Johnson And Johnson Limited Financial Performance

Figure 99: F Hoffmann La Roche Ltd Financial Performance

Figure 100: AbbVie Inc Financial Performance

Figure 101: Bayer AG Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Global Proliferative Diabetic Retinopathy (PDR) Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Proliferative Diabetic Retinopathy (PDR) Market, Competitive Dashboard

Figure 105: Global Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 107: Global, Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), Segmentation By Mode of Administration, 2025 – 2030

Figure 108: Global, Proliferative Diabetic Retinopathy (PDR) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Clinical Data Analytics Solutions Global Market Report 2025 – By Solution (Platform, Services), By Deployment (On-Premise, Cloud-Based), By Application (Clinical Decision Support, Precision Health, Quality Improvement An...

Pharmacy Automation Solution Global Market Report 2025 – By Type (Automated Medication Dispensing, Automated Packaging And Labeling, Automated Storage And Retrieval, Automated Medication Compounding, Other Types), By Aut...

Unit Dose Manufacturing Global Market Report 2025 – By Product (Liquid Unit Dose, Solid Unit Dose, Other Products), By Sourcing (In-House, Outsourcing), By End-User (Independent Pharmacies, Long Term Care Facility, Hospi...

Ketolides Global Market Report 2025 – By Drug Type (Telithromycin, Cethromycin, Solithromycin), By Indication (Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis), By Microorganism (Streptococcus Pneumoniae, Ha...

Geotourism Market Report 2026 - Global Outlook – By Tour Type (Individual Travel, Professional Groups, Group Travels), By Tourism Type (Sustainable Tourism, Urban Geo-Tourism, Rural Geo-Tourism, Natural Tourism, Eco Geo-...

Printed Circuit Board Market 2025 – By Type (Single Sided, Double Sided, Multi-Layer, High Density Interconnect (HDI), Other Types), By Substrate (Rigid, Flexible, Rigid-Flex), By Laminate Type (FR-4, Polyimide, Other La...

Frequently Asked Questions

What is the projected market size of the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market by 2030?

The Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market was valued at $2.69 billion in 2025, increased to $2.96 billion in 2026, and is projected to reach $4.49 billion by 2030. request a sample here

What is the expected CAGR for the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market during the forecast period 2025–2030 is 11.0%. request a sample here

What are the key factors driving the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market?

Major growth driver of the market includes: Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopathy (PDR) Market in the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market report?

The proliferative diabetic retinopathy (pdr) market covered in this report is segmented –
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy
2) By Mode of Administration: Injectables, Intravitreal Administration Focus, Other Mode Of Administrations
3) By Application: Hospitals, Clinics, Other Applications Subsegments:
1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab
2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide
3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation
4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy request a sample here

What is the anticipated growth trend for the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market?

Major trend in this market includes: Innovative Solutions For Early Detection And Improved Patient Outcomes For further insights on this market, request a sample here.

Who are the key players in the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market?

Major companies operating in the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market are Major companies operating in the proliferative diabetic retinopathy (pdr) market are Johnson And Johnson Limited, F Hoffmann La Roche Ltd, AbbVie Inc, Bayer AG, Novartis AG, Merck KGaA, Kubota Vision Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Mylan NV, Santen Pharmaceutical Co Ltd, Lupin Limited, Genentech Inc, Alcon Inc, Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co Ltd, Bausch And Lomb Corporation, Heidelberg Engineering GmbH, Iridex Corporation, Lumenis Ltd, Optos plc, Zeiss Meditec India Pvt Ltd, Alimera Sciences Inc request a sample here.

Which region has the most growth potential in the Proliferative Diabetic Retinopathy (PDR) Market Report 2026 market?

North America was the largest region in the proliferative diabetic retinopathy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proliferative diabetic retinopathy (pdr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.